文献速递哮喘慢阻肺

中国与新西兰症状性气道疾病表型比较

Phenotypes of symptomatic airways disease in China and New Zealand.
PubMed 文献 · Eur Respir J · 2017-12-07

该横断面观察研究纳入新西兰和中国40-75岁、近12个月有喘息和呼吸困难症状的成人,对345名完整数据者基于12项变量进行层次聚类分析,识别出五种气道疾病表型;分国分析模式相似,但新西兰人群出现独特的肥胖/共病表型。

要点

  • 症状性气道疾病可聚类为五种表型,包括两种哮喘/COPD重叠组和一种2型优势哮喘组。
  • 中国与新西兰人群的表型模式总体相似,提示遗传和环境差异下仍存在共同重叠表型。
  • 新西兰人群额外出现肥胖/共病表型,提示西方人群可能存在独特临床亚型。

核心结论

  • 不同遗传和环境特征人群中存在相似的哮喘/COPD重叠表型,西方人群可见肥胖/共病表型。

研究设计与样本

  • 横断面观察研究,从新西兰和中国一般人群随机选取40-75岁、近12个月有喘息和呼吸困难者。
  • 345名参与者有完整聚类分析数据,基于12项变量进行层次聚类分析。

主要发现

  • 合并数据集聚类分析描述五种表型:严重晚发哮喘/COPD重叠组、中度严重早发哮喘/COPD重叠组、2型优势中重度哮喘组,以及两个气流受限轻微但发病年龄不同的组。
  • 分国分析显示相似模式,但新西兰人群观察到独特的肥胖/共病组。

关键数值与推荐

  • 聚类分析基于12项变量:FEV1、FEV1/FVC比值、支气管舒张剂可逆性、PEF变异率、DLCO转运系数、FeNO、总IgE、CRP、症状发病年龄、BMI、健康状况和吸烟暴露。

临床怎么用

  • 临床识别哮喘/COPD重叠表型时需考虑发病年龄和2型炎症特征,西方人群还应关注肥胖与共病。

局限性

  • 横断面设计无法确定因果关系,样本仅限有症状成人且完整数据者345名,分国分析样本量可能有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

It is uncertain whether phenotypes of asthma and chronic obstructive pulmonary disease (COPD) vary between populations with different genetic and environmental characteristics. Here, our objective was to compare the phenotypes of airways disease in two separate populations.This was a cross-sectional observational study in adult populations from New Zealand and China. Participants aged 40-75 years who reported wheeze and breathlessness in the last 12 months were randomly selected from the general population and underwent detailed characterisation. Complete data for cluster analysis were available for 345 participants. Hierarchical cluster analysis was undertaken, based on 12 variables: forced expiratory volume in 1 s (FEV1), FEV1/forced vital capacity ratio, bronchodilator reversibility, peak expiratory flow variability, transfer coefficient of the lung for carbon monoxide, exhaled nitric oxide fraction, total IgE, C-reactive protein, age of symptom onset, body mass index, health status and cigarette smoke exposure.Cluster analysis of the combined dataset described five phenotypes: "severe late-onset asthma/COPD overlap group", "moderately severe early-onset asthma/COPD overlap group", "moderate to severe asthma group with type 2 predominant disease", and two groups with minimal airflow obstruction, differentiated by age of onset. Separate analyses by country showed similar patterns; however, a distinct obese/comorbid group was observed in the New Zealand population.Cluster analysis of adults with symptomatic airways disease suggests the presence of similar asthma/COPD overlap phenotypes within populations with different genetic and environmental characteristics, and an obese/comorbid phenotype in a Western population.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Fingleton J, Huang K, Weatherall M, et al. Phenotypes of symptomatic airways disease in China and New Zealand. Eur Respir J. 2017. PMID: 29217598. doi:10.1183/13993003.00957-2017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。